# Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation

> **NCT05797376** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 92 (actual)

## Conditions studied

- Atherosclerosis of Artery
- Coronary Artery Disease
- Peripheral Arterial Disease
- Carotid Stenosis

## Interventions

- **DRUG:** Rivaroxaban 2.5mg

## Key facts

- **NCT ID:** NCT05797376
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-24
- **Primary completion:** 2024-11-12
- **Final completion:** 2024-12-05
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797376, "Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05797376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*